264. The Rounds Table- Top 5 RCTs of 2024

Send us Fan MailIn this episode, we break down an approach to proteinuria, focusing on the interpretation of the urine dipstick, the urine ACR, and the urine PCR. Written by Dr. Ishmam Bhuiyan (Internal Medicine Resident at UBC). Reviewed by Dr. Teresa Tai (General Internist at R ...  Show more

Send us Fan MailIn this episode, we discuss updates to diagnosing and managing Acute Respiratory Distress Syndrome (ARDS). Written by Dr. Jason Vaillancourt (Internal Medicine Resident) and Dr. Muralie Vignarajah (Internal Medicine Resident). Reviewed by Dr. Christine D’Arsigny ( ...  Show more

Vulnerable plaque and scientific method; industry payments to trainees; tirzepatide or semaglutide; trial interpretation; and PFA are the topics John Mandrola, MD, covers in today's podcast.

This podcast is intended for healthcare professionals only.

To ...

Listener feedback on PFA and STEMI/NSTEMI paradigm, oral semaglutide, symptomatic vs asymptomatic AF, and the win-ratio are the topics John Mandrola, MD, discusses in this week's podcast.

This podcast is intended for healthcare professionals only.

To rea ...

The BackTable ENT show is closing out 2024 with gratitude, reflections, and plans for the year to come! In this episode of the Backtable ENT Podcast, hosts Dr. Ashley Agan and Dr. Gopi Shah celebrate a year of growth and milestones, including reaching 200 episodes and expanding t ...  Show more

An Impella update, another TAVI vs SAVR trial, two studies on angina and PCI, another null substudy from REVIVED-BCIS, and semaglutide are the topics John Mandrola, MD, covers in this week's podcast.

This podcast is intended for healthcare professionals only.</ ...